These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 19862529

  • 21. [Respiratory complications of new treatments for rheumatoid arthritis].
    Lioté H.
    Rev Mal Respir; 2004 Dec; 21(6 Pt 1):1107-15. PubMed ID: 15767955
    [Abstract] [Full Text] [Related]

  • 22. Adverse events with disease modifying antirheumatic drugs (DMARD): a cohort study of leflunomide compared with other DMARD.
    Cannon GW, Holden WL, Juhaeri J, Dai W, Scarazzini L, Stang P.
    J Rheumatol; 2004 Oct; 31(10):1906-11. PubMed ID: 15468352
    [Abstract] [Full Text] [Related]

  • 23. Liver toxicity is rare in rheumatoid arthritis patients using combination therapy with leflunomide and methotrexate.
    Alves JA, Fialho SC, Morato EF, Castro GR, Zimmermann AF, Ribeiro GG, Neves FS, Pereira IA.
    Rev Bras Reumatol; 2011 Oct; 51(2):141-4. PubMed ID: 21584420
    [Abstract] [Full Text] [Related]

  • 24. The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis.
    Bird P, Griffiths H, Tymms K, Nicholls D, Roberts L, Arnold M, Burnet S, de Jager J, Scott J, Zochling J, Littlejohn G.
    J Rheumatol; 2013 Mar; 40(3):228-35. PubMed ID: 23322457
    [Abstract] [Full Text] [Related]

  • 25. Leflunomide-associated infections in rheumatoid arthritis.
    Jenks KA, Stamp LK, O'Donnell JL, Savage RL, Chapman PT.
    J Rheumatol; 2007 Nov; 34(11):2201-3. PubMed ID: 17937473
    [Abstract] [Full Text] [Related]

  • 26. Treatment options for rheumatoid arthritis: celecoxib, leflunomide, etanercept, and infliximab.
    Luong BT, Chong BS, Lowder DM.
    Ann Pharmacother; 2000 Jun; 34(6):743-60. PubMed ID: 10860137
    [Abstract] [Full Text] [Related]

  • 27. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.
    Sharp JT, Strand V, Leung H, Hurley F, Loew-Friedrich I.
    Arthritis Rheum; 2000 Mar; 43(3):495-505. PubMed ID: 10728741
    [Abstract] [Full Text] [Related]

  • 28. A large pulmonary nodule in a rheumatoid arthritis patient treated with tofacitinib.
    Her M, Park J, Lee SG.
    Int J Rheum Dis; 2024 Jan; 27(1):e15013. PubMed ID: 38140794
    [Abstract] [Full Text] [Related]

  • 29. Leflunomide-related acute interstitial pneumonia in two patients with rheumatoid arthritis: autopsy findings with a mosaic pattern of acute and organizing diffuse alveolar damage.
    Ochi S, Harigai M, Mizoguchi F, Iwai H, Hagiyama H, Oka T, Miyasaka N.
    Mod Rheumatol; 2006 Jan; 16(5):316-20. PubMed ID: 17039315
    [Abstract] [Full Text] [Related]

  • 30. Comparative effectiveness of rituximab in combination with either methotrexate or leflunomide in the treatment of rheumatoid arthritis.
    Narváez J, Díaz-Torné C, Ruiz JM, Hernández MV, Torrente-Segarra V, Ros S, Rodriguez de la Serna A, Díaz-López C, Sanmartí R, Nolla JM.
    Semin Arthritis Rheum; 2011 Dec; 41(3):401-5. PubMed ID: 21862107
    [Abstract] [Full Text] [Related]

  • 31. Risk factors of severe infections in patients with rheumatoid arthritis treated with leflunomide.
    Yoo HG, Yu HM, Jun JB, Jeon HS, Yoo WH.
    Mod Rheumatol; 2013 Jul; 23(4):709-15. PubMed ID: 22791271
    [Abstract] [Full Text] [Related]

  • 32. Rheumatoid arthritis with pulmonary accelerated rheumatoid nodules treated by baricitinib: a case-based review.
    Liu H, Li Q, Long K, Xia O, Ye Y, Wang H, Dai L.
    Clin Rheumatol; 2024 Feb; 43(2):775-784. PubMed ID: 37740125
    [Abstract] [Full Text] [Related]

  • 33. Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review.
    Roubille C, Haraoui B.
    Semin Arthritis Rheum; 2014 Apr; 43(5):613-26. PubMed ID: 24231065
    [Abstract] [Full Text] [Related]

  • 34. [Pleuro-pericarditis developed under a leflunomide therapy].
    Vandenbos F, Figueredo M, Tarhini A, Ribière J.
    Rev Pneumol Clin; 2015 Feb; 71(1):57-9. PubMed ID: 25457216
    [Abstract] [Full Text] [Related]

  • 35. Leflunomide treatment in elderly patients with rheumatoid or psoriatic arthritis: retrospective analysis of safety and adherence to treatment.
    Alivernini S, Mazzotta D, Zoli A, Ferraccioli G.
    Drugs Aging; 2009 Feb; 26(5):395-402. PubMed ID: 19552491
    [Abstract] [Full Text] [Related]

  • 36. Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial.
    Kremer J, Genovese M, Cannon GW, Caldwell J, Cush J, Furst DE, Luggen M, Keystone E, Bathon J, Kavanaugh A, Ruderman E, Coleman P, Curtis D, Kopp E, Kantor S, Weisman M, Waltuck J, Lindsley HB, Markenson J, Crawford B, Fernando I, Simpson K, Strand V.
    J Rheumatol; 2004 Aug; 31(8):1521-31. PubMed ID: 15290730
    [Abstract] [Full Text] [Related]

  • 37. Methotrexate versus leflunomide in rheumatoid arthritis: what is new in 2011?
    Singer O, Gibofsky A.
    Curr Opin Rheumatol; 2011 May; 23(3):288-92. PubMed ID: 21378570
    [Abstract] [Full Text] [Related]

  • 38. Infliximab and leflunomide combination therapy in rheumatoid arthritis: an open-label study.
    Kiely PD, Johnson DM.
    Rheumatology (Oxford); 2002 Jun; 41(6):631-7. PubMed ID: 12048288
    [Abstract] [Full Text] [Related]

  • 39. Accelerated pulmonary nodulosis and sterile pleural effusion in a patient with psoriatic arthropathy during methotrexate therapy: a case report.
    Balbir-Gurman A, Guralnik L, Best LA, Vlodavsky E, Yigla M, Menahem Nahir A, Braun-Moscovici Y.
    J Clin Rheumatol; 2009 Feb; 15(1):29-30. PubMed ID: 18679135
    [Abstract] [Full Text] [Related]

  • 40. Life-threatening reversible bone marrow toxicity in a rheumatoid arthritis patient switched from leflunomide to infliximab.
    Marchesoni A, Arreghini M, Panni B, Battafarano N, Uziel L.
    Rheumatology (Oxford); 2003 Jan; 42(1):193-4. PubMed ID: 12509641
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.